Your symptoms made sense. We treat what they were managing.
If fentanyl and fentanyl analogues use is part of what you’re carrying, we start with mental health and trauma. Healing begins in our Partial Hospitalization Program: a focused day of care, and home every night.
Call Women’s Recovery at 833.754.0554 to share your concerns and explore a next step without pressure.
These are rooms at our Denver office. You spend the day here, and you go home at night.
fentanyl and fentanyl analogues use treatment for women in Denver provides general research context. NIDA identifies methadone, buprenorphine, and naltrexone as FDA-approved medications that can help people stop or reduce opioid use, while lofexidine treats acute opioid-withdrawal symptoms. This is not a personal medication recommendation. Consult the contact page for published details.
Supporting guidance: Fentanyl | National Institute on Drug Abuse (NIDA) Medications for Opioid Use Disorder
Fentanyl and fentanyl analogues use treatment for women in Denver may include lofexidine for acute withdrawal symptoms or methadone, buprenorphine, and naltrexone as part of ongoing opioid addiction treatment for women. These medications may ease withdrawal symptoms, reduce cravings, or help someone stop or reduce opioid use. An admissions conversation can be a first step toward discussing treatment.
Your experience may be affected by how often fentanyl was used, other substances or medications, physical health, and prior withdrawal experiences. Because illicitly manufactured fentanyl may appear in other drugs without someone knowing, an assessment should cover everything you may have taken, even when you are uncertain what it contained.
Addiction, or opioid use disorder, also involves patterns such as difficulty controlling use or continuing despite harm. They can overlap, but they are not identical. A clinician can assess both and discuss whether medication, closer medical support, and a particular level of care fit your needs rather than relying on a single symptom.
Treatment commonly combines medication with behavioral and practical support shaped around your circumstances. Depending on an individual assessment, possible settings may include fentanyl and fentanyl analogues outpatient addiction treatment for women or a more structured fentanyl and fentanyl analogues Intensive Outpatient Program (IOP) addiction treatment for women.
Methadone, buprenorphine, and naltrexone are approved to treat opioid use disorder, although they work differently and are not interchangeable for every person. Counseling and other supports can address triggers, coping skills, mental health concerns, relationships, and routines. A qualified professional should help determine which combination is appropriate based on your health, goals, current use, and treatment history.
You may need to discuss work, caregiving, transportation, privacy, housing stability, exposure to fentanyl, physical health, and support at home. More structure is not automatically better, and greater flexibility is not automatically safer. An assessment can weigh those realities alongside overdose risk, withdrawal needs, other substance use, and your ability to participate consistently before making an individual recommendation.
Naloxone can reverse an opioid overdose, including an overdose involving fentanyl. If someone may be overdosing, administer naloxone if available and call 911 immediately. Emergency help is still necessary. Learning about overdose response can be part of opioid addiction treatment for women, and you can contact Women’s Recovery with nonemergency treatment questions.
Combining opioids with other substances, intentionally or unknowingly, increases the risk of serious harm. A recent overdose, unexpected exposure, or increasingly unpredictable use deserves prompt attention in treatment. Naloxone can reverse an opioid overdose involving fentanyl. If someone may be overdosing, administer naloxone if available and call 911 immediately.
A care conversation can consider immediate medical needs, withdrawal risk, access to medication for opioid use disorder, and whether your current environment offers enough safety and support. Loved ones can share what they have observed while leaving space for you to describe what happened, what feels manageable, and what you are willing to consider.
women’s treatment programs may involve appointments followed by a return home the same day. You can also review admissions information when deciding whether a conversation about outpatient care feels helpful.
Explore care at our Denver location and communities we serve for related guidance. Call admissions when you want to discuss your own situation.
Call AdmissionsThe appropriate level of care depends on your withdrawal and overdose risk, use of other substances, physical and mental health, home safety, prior care, responsibilities, and available support. An individualized assessment can match you with a setting that offers suitable structure and support while accounting for your daily life and safety.
Yes. Illicitly manufactured fentanyl may be added to other drugs without your knowledge, so uncertainty about exposure does not prevent you from seeking care and may itself warrant prompt clinical attention. If an overdose may be happening, seek emergency help immediately.
No. Methadone and buprenorphine act on opioid receptors, but they work differently from fentanyl and can reduce withdrawal symptoms and cravings without fentanyl’s intense pleasurable effects. Naltrexone works differently by blocking opioid effects. A medical professional can explain benefits, limitations, and which option may fit your circumstances.
NIDA states that medications are the standard treatment for fentanyl addiction. Its opioid-use-disorder information identifies methadone, buprenorphine, and naltrexone as FDA-approved medications that can help people stop or reduce opioid use. Lofexidine is available for acute opioid-withdrawal symptoms. This general information does not establish whether any particular facility currently provides these treatments.
Women’s Recovery’s public contact page lists its Denver location at 3801 E Florida Ave, Ste 650, Denver, CO 80210. The published contact number is 833.754.0554. These details establish only the publicly listed address and phone number; they do not establish licensing, accreditation, treatment availability, eligibility, schedules, outcomes, or information about another facility.
Read how we select health information sources and apply the Women’s Recovery editorial policy. These references provide general education and context; they do not establish an individual diagnosis, service, or treatment recommendation.
If you can't believe that yet, borrow my hope. Just long enough to find your own.
Women’s Recovery graduate
